These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36495858)

  • 1. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study.
    Sánchez-Torres AM; Amoretti S; Enguita-Germán M; Mezquida G; Moreno-Izco L; Panadero-Gómez R; Rementería L; Toll A; Rodriguez-Jimenez R; Roldán A; Pomarol-Clotet E; Ibáñez Á; Usall J; Contreras F; Vieta E; López-Ilundain JM; Merchán-Naranjo J; González-Pinto A; Berrocoso E; Bernardo M; Cuesta MJ;
    Eur Neuropsychopharmacol; 2023 Feb; 67():53-65. PubMed ID: 36495858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationships between cognitive reserve, cognitive functioning and quality of life in first-episode schizophrenia spectrum disorders.
    Rodriguez M; Knížková K; Keřková B; Siroňová A; Šustová P; Jonáš J; Španiel F
    Psychiatry Res; 2022 Apr; 310():114479. PubMed ID: 35231876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia.
    de la Serna E; Andrés-Perpiñá S; Puig O; Baeza I; Bombin I; Bartrés-Faz D; Arango C; Gonzalez-Pinto A; Parellada M; Mayoral M; Graell M; Otero S; Guardia J; Castro-Fornieles J
    Schizophr Res; 2013 Jan; 143(1):125-31. PubMed ID: 23182439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden.
    Cuesta MJ; Ballesteros A; Sánchez-Torres AM; Amoretti S; López-Ilundain JM; Merchán-Naranjo J; González-Ortega I; Salgado P; Rodriguez-Jimenez R; Roldán-Bejarano A; Sarró S; Ibáñez Á; Usall J; Escartí MJ; Moreno-Izco L; Mezquida G; Parellada M; González-Pinto A; Berrocoso E; Bernardo M;
    Schizophr Res; 2022 Oct; 248():331-340. PubMed ID: 36155307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study.
    Amoretti S; Bernardo M; Bonnin CM; Bioque M; Cabrera B; Mezquida G; Solé B; Vieta E; Torrent C
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1638-48. PubMed ID: 27511320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients.
    Chen EY; Hui CL; Dunn EL; Miao MY; Yeung WS; Wong CK; Chan WF; Tang WN
    Schizophr Res; 2005 Sep; 77(1):99-104. PubMed ID: 16005389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses.
    Amoretti S; Rosa AR; Mezquida G; Cabrera B; Ribeiro M; Molina M; Bioque M; Lobo A; González-Pinto A; Fraguas D; Corripio I; Vieta E; de la Serna E; Morro L; Garriga M; Torrent C; Cuesta MJ; Bernardo M;
    Psychol Med; 2022 Feb; 52(3):526-537. PubMed ID: 32900395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive reserve and its correlates in child and adolescent offspring of patients diagnosed with schizophrenia or bipolar disorder.
    Camprodon-Boadas P; Rosa-Justicia M; Sugranyes G; Moreno D; Baeza I; Ilzarbe D; Martínez Díaz-Caneja C; Ayora M; Merchan J; Martín N; Borras R; García-Rizo C; Torrent C; Castro-Fornieles J; de la Serna E
    Eur Child Adolesc Psychiatry; 2023 Aug; 32(8):1463-1473. PubMed ID: 35175425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between cognitive reserve and the clinical stage of HIV infection.
    Alvarez-Tostado P; Inozemtseva O; Aguiñiga MA; López E; Matute E
    AIDS Care; 2016; 28(5):633-8. PubMed ID: 26711542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.
    Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
    Eur Psychiatry; 2013 Aug; 28(6):332-9. PubMed ID: 22999439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-episode schizophrenia patients neuropsychologically within the normal limits: evidence of deterioration in speed of processing.
    González-Blanch C; Rodríguez-Sánchez JM; Pérez-Iglesias R; Pardo-García G; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2010 Jun; 119(1-3):18-26. PubMed ID: 20335007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive reserve as a moderator of outcomes in five clusters of first episode psychosis patients: a 10-year follow-up study of the PAFIP cohort.
    Ayesa-Arriola R; de la Foz VO; Murillo-García N; Vázquez-Bourgon J; Juncal-Ruiz M; Gómez-Revuelta M; Suárez-Pinilla P; Setién-Suero E; Crespo-Facorro B
    Psychol Med; 2023 Apr; 53(5):1891-1905. PubMed ID: 37310335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive reserve attenuates age-related cognitive decline in the context of putatively accelerated brain ageing in schizophrenia-spectrum disorders.
    Van Rheenen TE; Cropley V; Fagerlund B; Wannan C; Bruggemann J; Lenroot RK; Sundram S; Weickert CS; Weickert TW; Zalesky A; Bousman CA; Pantelis C
    Psychol Med; 2020 Jul; 50(9):1475-1489. PubMed ID: 31274065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode.
    Zanelli J; Mollon J; Sandin S; Morgan C; Dazzan P; Pilecka I; Reis Marques T; David AS; Morgan K; Fearon P; Doody GA; Jones PB; Murray RM; Reichenberg A
    Am J Psychiatry; 2019 Oct; 176(10):811-819. PubMed ID: 31256609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis.
    Amoretti S; Cabrera B; Torrent C; Mezquida G; Lobo A; González-Pinto A; Parellada M; Corripio I; Vieta E; de la Serna E; Butjosa A; Contreras F; Sarró S; Penadés R; Sánchez-Torres AM; Cuesta M; Bernardo M;
    Acta Psychiatr Scand; 2018 Nov; 138(5):441-455. PubMed ID: 30105820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive reserve and working memory in cognitive performance of adults with subjective cognitive complaints: longitudinal structural equation modeling.
    Lojo-Seoane C; Facal D; Guàrdia-Olmos J; Pereiro AX; Campos-Magdaleno M; Mallo SC; Juncos-Rabadán O
    Int Psychogeriatr; 2020 Apr; 32(4):515-524. PubMed ID: 31547899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life.
    Anaya C; Torrent C; Caballero FF; Vieta E; Bonnin Cdel M; Ayuso-Mateos JL;
    Acta Psychiatr Scand; 2016 May; 133(5):386-98. PubMed ID: 26719018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.